Авторы

  • Самарина К.С., Ассесорова Ю.Ю.

Ключевые слова:

хронический миелолейкоз, гомоцистеин, гемостаз, тромбоз.

Библиографические ссылки

Андрианова М.Ю., Ройтман Е.В., Исаева А.М., и др. Патогенетическое и клиническое обоснование комплексной профилактики гипергомоцистеинемии // Архив внутренней медицины, 2014. –(4), 32–38.

Туркина А.Г., Зарицкий А.Ю., Шуваев В.А., и др. Клинические рекомендации по диагностике и лечению хронического миелолейкоза // Клиническая онкогематология. – 2017. – Т. 10, № 3. – С. 294–316.

Челышева Е.Ю., Петрова А.Н., Шухов О.А., и др. Результаты наблюдения за пациентами с хроническим миелолейкозом с глубоким молекулярным ответом без терапии ингибиторами тирозинкиназ: исторический опыт и данные проспективного многоцентрового исследования // Гематология и трансфузиология. – 2020. – Т. 65, № 1. – С. 52.

Chai–Adisaksopha C, Lam W, Hillis C. Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta–analysis. Leuk Lymphoma. 2016;57(6):1300–10. doi: 10.3109/10428194.2015.1091929.

Fossard G, Blond E, Balsat M, et al. Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients. Haematologica. 2016 Mar; 101(3):e86–90. doi: 10.3324/haematol.2015. 135103.

Haguet H, Bouvy C, Delvigne AS, et al. The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR–ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In–Vitro Study. Front Pharmacol. 2020 Jul 3;11:1007. doi: 10.3389/fphar.2020.01007.

Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020 Apr; 34(4): 966–984. doi: 10.1038/s41375–020–0776–2.

Hochhaus A., Saussele S., Rosti G., et al. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow–up // Ann. Oncol. – 2017. – Vol. 41, № 4. – P. 51.

Khan MS, Saeedullah A, Andrews SC, et al. Adolescent Afghan Refugees Display a High Prevalence of Hyperhomocysteinemia and Associated Micronutrients Deficiencies Indicating an Enhanced Risk of Cardiovascular Disease in Later Life. Nutrients. 2022 Apr 22; 14(9): 1751. doi: 10.3390/ nu140 91751.

Lang K, McGarry LJ, Huang H, et al. Mortality and Vascular Events Among Elderly Patients with Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER–Medicare Data. Clin Lymphoma Myeloma Leuk. 2016 May;16(5):275–285.e1. doi: 10.1016/j.clml.2016.01.006.

Ma Y, Zhang Z, Chen R, et al. NRP1 regulates HMGB1 in vascular endothelial cells under high homocysteine condition. Am J Physiol Heart Circ Physiol. 2019 May 1; 316(5): H1039–H1046. doi: 10.1152/ajpheart.00746.2018.

Pearson E, McGarry L, Gala S, et al. Disease–related mortality exceeds treatment–related mortality in patients with chronic myeloid leukemia on second–line or later therapy. Leuk Res. 2016 Apr; 43:1–8. doi: 10.1016/j.leukres.2016.02.001.

Shi J, Chen D, Wang Z, Li S, Zhang S. Homocysteine induces ferroptosis in endothelial cells through the systemXc–/GPX4 signaling pathway. BMC Cardiovasc Disord. 2023 Jun 24;23(1):316. doi: 10.1186/s12872–023–03342–4. Erratum in: BMC Cardiovasc Disord. 2023 Jul 17; 23(1):356. doi: 10.11 86/s12872–023–03384–8.

Shi Z, Guan Y, Huo YR, et al. Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long–Term Mortality. Stroke. 2015 Sep; 46(9): 2419–25. doi: 10.1161/STROKE-AHA.115.009136.

Vener C, Rossi S, Minicozzi P, et al. EUROCARE–6 Working Group. Clear Improvement in Real–World Chronic Myeloid Leukemia Survival: A Comparison with Randomized Controlled Trials. Front Oncol. 2022 Jul 14; 12: 892684. doi: 10.3389/fonc. 2022.892684.

Wang B, Mo X, Wu Z, Guan X. Systematic review and meta–analysis of the correlation between plasma homocysteine levels and coronary heart disease. J Thorac Dis. 2022 Mar;14(3):646–653. doi: 10.21037/jtd–22–78.

Wang D, Cao Z, Li Z, et al. Homocysteine and Clinical Outcomes in Intracerebral Hemorrhage Patients: Results from the China Stroke Center Alliance. Neuropsychiatr Dis Treat. 2022 Dec 7; 18: 2837–2846. doi: 10.2147/NDT.S391618.

Xie R, Jia D, Gao C, et al. Homocysteine induces procoagulant activity of red blood cells via phosphatidylserine exposure and microparticles generation. Amino Acids. 2014 Aug;46(8):1997–2004. doi: 10.1007/s00726–014–1755–6.

Yoshitomi R, Nakayama K, Yamashita S, et al. Plasma Homocysteine Concentration is Associated with the Expression Level of Folate Receptor 3. Sci Rep. 2020 Jun 24;10(1):10283. doi: 10.1038/s4 1598–020–67288–9.